Atherosclerosis
Volume 183, Issue 1 , Pages 17-24 , November 2005

Pulse pressure-driven neutral lipid accumulation and correlative proinflammatory markers of accelerated atherogenesis

Received 19 May 2004 ,Revised 12 January 2005 ,Accepted 15 February 2005.

References 

  1. Woolf N. Morphological changes in atherosclerosis and the effects of hyperlipidemia on the artery wall. Atheroscler Rev. 1988;18:25–48
  2. Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Atheroscler Rev. 1988;18:1–23
  3. Chapman MJ, Guerin M, Bruckert E. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur Heart J. 1998;19(Suppl. A):A24–A30
  4. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551–561
  5. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323–340
  6. Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atheroscler Suppl. 2002;3:3–9
  7. Kiefer CR, McKenney JB, Trainor JF, Snyder LM. Maturation-dependent acquired coronary structural alterations and atherogenesis in the Dahl sodium-sensitive hypertensive rat. Circulation. 2002;106:2486–2490
  8. Bobryshev YV, Lord RSA. Accumulation of co-localised unesterified cholesterol and neutral lipids within vacuolised elastin fibres in athero-prone areas of the human aorta. Atherosclerosis. 1999;142:121–131
  9. Hulthe J, Wikstrand J, Mattsson-Hultén L, Fagerberg B. Circulating ICAM-I (intercellular cell-adhesion molecule I) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond). 2002;103:123–129
  10. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol. 2002;22:1162–1167
  11. Toikka JO, Laine H, Ahotupa M, et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000;36:929–933
  12. Bhakdi S, Torzewski M, Klouche M, Hemmes M. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol. 1999;19:2348–2354
  13. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima. Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20:2094–2099
  14. Wang H-W, Sui S-f. Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun. 2001;288:75–79
  15. Ahotupa M, Ruutu M, Mäntylä E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem. 1996;29:139–144
  16. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res. 1983;24:904–909
  17. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in Circulation Research. Circ Res. 1980;47:1–9
  18. Wassertheil-Smoller S, Blaufox D, Oberman AS, et al. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med. 1992;152:131–136
  19. Rassouli M, Sambasivam H, Azadi P, et al. Derivation of the amino acid sequence of rat C-reactive protein from cDNA cloning with additional studies on the nature of its dimeric component. J Biol Chem. 1992;267:2947–2954
  20. Kvasnicka T, Kvasnicka J, Ceska R, Grauova B, Vrablik M. Increasing plasma levels of soluble cell adhesion molecules (sE-selectin, sP-selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek. 2001;102:473–477
  21. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399–403
  22. Preston RA, Ledford M, Materson BJ, et al. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor. J Hypertens. 2002;20:871–877
  23. Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens. 2001;19:863–869
  24. Fang J, Madhavan S, Alderman MH. Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects. Blood Press. 2000;9:260–266
  25. Nigam A, Mitchell GF, Lambert J, Tardif J-C. Relation between conduit vessel stiffhess (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92:395–399
  26. Sakurada T, Orimo H, Okabe H, Noma A, Murakami M. Purification and properties of cholesterol ester hydrolase from human aortic intima and media. Biochim Biophys Acta. 1976;424:204–212

PII: S0021-9150(05)00166-8

doi: 10.1016/j.atherosclerosis.2005.02.023

Atherosclerosis
Volume 183, Issue 1 , Pages 17-24 , November 2005

Article Tools

* Image Usage & Resolution